CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 230 filers reported holding CANTEL MEDICAL CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,167,000 | -12.6% | 14,617 | -13.7% | 0.18% | -18.3% |
| Q4 2020 | $1,335,000 | +50.3% | 16,930 | -16.2% | 0.22% | +30.2% |
| Q3 2020 | $888,000 | -15.9% | 20,198 | -15.4% | 0.17% | -28.6% |
| Q2 2020 | $1,056,000 | +324.1% | 23,884 | +244.4% | 0.24% | +230.1% |
| Q1 2020 | $249,000 | -2.7% | 6,935 | +202.2% | 0.07% | +17.7% |
| Q1 2018 | $256,000 | +20.8% | 2,295 | +11.4% | 0.06% | +26.5% |
| Q4 2017 | $212,000 | +0.5% | 2,060 | -8.0% | 0.05% | -5.8% |
| Q3 2017 | $211,000 | -9.8% | 2,240 | -25.3% | 0.05% | -14.8% |
| Q2 2017 | $234,000 | -1.7% | 3,000 | +1.0% | 0.06% | -1.6% |
| Q1 2017 | $238,000 | +10.7% | 2,969 | +8.7% | 0.06% | +1.6% |
| Q4 2016 | $215,000 | 0.0% | 2,732 | -12.7% | 0.06% | -7.6% |
| Q2 2016 | $215,000 | 0.0% | 3,128 | +3.6% | 0.07% | -2.9% |
| Q1 2016 | $215,000 | +0.5% | 3,019 | -12.2% | 0.07% | -1.4% |
| Q4 2015 | $214,000 | – | 3,438 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DIKER MANAGEMENT LLC | 1,084,317 | $85,509,000 | 43.23% |
| Leonard Green & Partners, L.P. | 2,100,000 | $165,606,000 | 2.29% |
| Champlain Investment Partners, LLC | 3,952,620 | $311,704,000 | 1.79% |
| Brown Capital Management | 2,454,770 | $193,583,000 | 1.34% |
| Aurora Investment Counsel | 19,502 | $1,538,000 | 1.24% |
| Conestoga Capital Advisors, LLC | 797,481 | $62,889,000 | 1.00% |
| EMERALD ADVISERS, LLC | 292,554 | $23,071,000 | 0.77% |
| FRED ALGER MANAGEMENT, LLC | 3,470,340 | $273,671,000 | 0.71% |
| GENEVA CAPITAL MANAGEMENT LLC | 510,171 | $40,232,000 | 0.68% |
| WASHINGTON CAPITAL MANAGEMENT, INC | 7,650 | $603,000 | 0.58% |